The PC (proprotein convertase) furin cleaves a large variety of proproteins and hence plays a major role in many pathologies. Therefore furin inhibition might be a good strategy for therapeutic intervention, and several furin inhibitors have been generated, although none are entirely furin-specific. To reduce potential side effects caused by cross-reactivity with other proteases, dromedary heavy-chain-derived nanobodies against catalytically active furin were developed as specific furin inhibitors. The nanobodies bound only to furin but not to other PCs. Upon overexpression in cell lines, they inhibited the cleavage of two different furin substrates, TGFβ (transforming growth factor β) and GPC3 (glypican 3). Purified nanobodies could inhibit the cleavage of diphtheria toxin into its enzymatically active A fragment, but did not inhibit cleavage of a small synthetic peptide-based substrate, suggesting a mode-of-action based on steric hindrance. The dissociation constant of purified nanobody 14 is in the nanomolar range. The nanobodies were non-competitive inhibitors with an inhibitory constant in the micromolar range as demonstrated by Dixon plot. Furthermore, anti-furin nanobodies could protect HEK (human embryonic kidney)-293T cells from diphtheria-toxin-induced cytotoxicity as efficiently as the PC inhibitor nona-D-arginine. In conclusion, these antibody-based single-domain nanobodies represent the first generation of highly specific non-competitive furin inhibitors.
TAYLOR N. A., Curbing activation: proprotein convertases in homeostasis and pathology, 10.1096/fj.02-0831rev
Creemers John, W.M., Knock-out mouse models of proprotein convertases: unique functions or redundancy?, 10.2741/3055
Roebroek A, Development, 125, 4863 (1998)
Roebroek Anton J. M., Taylor Neil A., Louagie Els, Pauli Ilse, Smeijers Liesbeth, Snellinx An, Lauwers Annick, Van de Ven Wim J. M., Hartmann Dieter, Creemers John W. M., Limited Redundancy of the Proprotein Convertase Furin in Mouse Liver, 10.1074/jbc.m407152200
De Vos L, Int. J. Oncol., 32, 1073 (2008)
Essalmani Rachid, Susan-Resiga Delia, Chamberland Ann, Abifadel Marianne, Creemers John W., Boileau Catherine, Seidah Nabil G., Prat Annik, In VivoEvidence That Furin from Hepatocytes Inactivates PCSK9, 10.1074/jbc.m110.192104
Louagie E., Taylor N. A., Flamez D., Roebroek A. J. M., Bright N. A., Meulemans S., Quintens R., Herrera P. L., Schuit F., Van de Ven W. J. M., Creemers J. W. M., Role of furin in granular acidification in the endocrine pancreas: Identification of the V-ATPase subunit Ac45 as a candidate substrate, 10.1073/pnas.0800340105
Pesu Marko, Watford Wendy T., Wei Lai, Xu Lili, Fuss Ivan, Strober Warren, Andersson John, Shevach Ethan M., Quezado Martha, Bouladoux Nicolas, Roebroek Anton, Belkaid Yasmine, Creemers John, O’Shea John J., T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance, 10.1038/nature07210
Bassi Daniel E., Mahloogi Haleh, Al-Saleem Luma, Lopez De Cicco Ricardo, Ridge John A., Klein-Szanto Andres J. P., Elevated furin expression in aggressive human head and neck tumors and tumor cell lines, 10.1002/mc.1057
Lea N., Lord J. M., Roberts L. M., Proteolytic cleavage of the A subunit is essential for maximal cytotoxicity of Escherichia coli 0157:H7 Shiga-like toxin-1, 10.1099/13500872-145-5-999
Abrami Laurence, Fivaz Marc, Decroly Etienne, Seidah Nabil G., Jean François, Thomas Gary, Leppla Stephen H., Buckley J. Thomas, van der Goot F. Gisou, The Pore-forming Toxin Proaerolysin Is Activated by Furin, 10.1074/jbc.273.49.32656
Gonzalez-Reyes L., Ruiz-Arguello M. B., Garcia-Barreno B., Calder L., Lopez J. A., Albar J. P., Skehel J. J., Wiley D. C., Melero J. A., Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion, 10.1073/pnas.151098198
Maisner A, J. Gen. Virol., 81, 441 (2000)
Jean F., Thomas L., Molloy S. S., Liu G., Jarvis M. A., Nelson J. A., Thomas G., A protein-based therapeutic for human cytomegalovirus infection, 10.1073/pnas.050504297
Volchkov V. E., Feldmann H., Volchkova V. A., Klenk H.-D., Processing of the Ebola virus glycoprotein by the proprotein convertase furin, 10.1073/pnas.95.10.5762
Scamuffa Nathalie, Siegfried Geraldine, Bontemps Yannick, Ma Liming, Basak Ajoy, Cherel Ghislaine, Calvo Fabien, Seidah Nabil G., Khatib Abdel-Majid, Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells, 10.1172/jci32040
Sarac M. S., Cameron A., Lindberg I., The Furin Inhibitor Hexa-D-Arginine Blocks the Activation of Pseudomonas aeruginosa Exotoxin A In Vivo, 10.1128/iai.70.12.7136-7139.2002
Sarac M. S., Peinado J. R., Leppla S. H., Lindberg I., Protection against Anthrax Toxemia by Hexa-D-Arginine In Vitro and In Vivo, 10.1128/iai.72.1.602-605.2004
Shiryaev Sergey A., Remacle Albert G., Ratnikov Boris I., Nelson Nicholas A., Savinov Alexei Y., Wei Ge, Bottini Massimo, Rega Michele F., Parent Amelie, Desjardins Roxane, Fugere Martin, Day Robert, Sabet Mojgan, Pellecchia Maurizio, Liddington Robert C., Smith Jeffrey W., Mustelin Tomas, Guiney Donald G., Lebl Michal, Strongin Alex Y., Targeting Host Cell Furin Proprotein Convertases as a Therapeutic Strategy against Bacterial Toxins and Viral Pathogens, 10.1074/jbc.m703847200
Becker Gero L., Sielaff Frank, Than Manuel E., Lindberg Iris, Routhier Sophie, Day Robert, Lu Yinghui, Garten Wolfgang, Steinmetzer Torsten, Potent Inhibitors of Furin and Furin-like Proprotein Convertases Containing Decarboxylated P1 Arginine Mimetics, 10.1021/jm9012455
Cameron Angus, Appel Jon, Houghten Richard A., Lindberg Iris, Polyarginines Are Potent Furin Inhibitors, 10.1074/jbc.m003848200
Misumi Yoshio, Ohkubo Kumiko, Sohda Miwa, Takami Noboru, Oda Kimimitsu, Ikehara Yukio, Intracellular processing of complement pro-C3 and proalbumin is inhibited by rat α1-protease inhibitor variant (Met352→Arg) in transfected cells, 10.1016/0006-291x(90)91382-3
Van Rompaey L, Biochem. J., 326, 507 (1997)
Henrich Stefan, Lindberg Iris, Bode Wolfram, Than Manuel E., Proprotein Convertase Models based on the Crystal Structures of Furin and Kexin: Explanation of their Specificity, 10.1016/j.jmb.2004.10.050
Coppola Julia M., Hamilton Christin A., Bhojani Mahaveer S., Larsen Martha J., Ross Brian D., Rehemtulla Alnawaz, Identification of inhibitors using a cell-based assay for monitoring Golgi-resident protease activity, 10.1016/j.ab.2007.01.013
Jiao G.-S., Cregar L., Wang J., Millis S. Z., Tang C., O'Malley S., Johnson A. T., Sareth S., Larson J., Thomas G., Synthetic small molecule furin inhibitors derived from 2,5-dideoxystreptamine, 10.1073/pnas.0606555104
Conrath K. E., Lauwereys M., Galleni M., Matagne A., Frere J.-M., Kinne J., Wyns L., Muyldermans S., -Lactamase Inhibitors Derived from Single-Domain Antibody Fragments Elicited in the Camelidae, 10.1128/aac.45.10.2807-2812.2001
Lauwereys M., Potent enzyme inhibitors derived from dromedary heavy-chain antibodies, 10.1093/emboj/17.13.3512
Nguyen Viet Khong, Hamers Raymond, Wyns Lode, Muyldermans Serge, Camel heavy-chain antibodies: diverse germline VHH and specific mechanisms enlarge the antigen-binding repertoire, 10.1093/emboj/19.5.921
De Genst E., Silence K., Decanniere K., Conrath K., Loris R., Kinne J., Muyldermans S., Wyns L., Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies, 10.1073/pnas.0505379103
Creemers John W.M., Kormelink Paul J.Groot, Roebroek Anton J.M., Nakayama Kazuhisa, Van de Ven Wim J.M., Proprotein processing activity and cleavage site selectivity of the Kex2-like endoprotease PACE4, 10.1016/0014-5793(93)81610-c
Creemers John W. M., Pritchard Lynn E., Gyte Amy, Le Rouzic Philippe, Meulemans Sandra, Wardlaw Sharon L., Zhu Xiaorong, Steiner Donald F., Davies Nicola, Armstrong Duncan, Lawrence Catherine B., Luckman Simon M., Schmitz Catherine A., Davies Rick A., Brennand John C., White Anne, Agouti-Related Protein Is Posttranslationally Cleaved by Proprotein Convertase 1 to Generate Agouti-Related Protein (AGRP)83–132: Interaction between AGRP83–132and Melanocortin Receptors Cannot Be Influenced by Syndecan-3, 10.1210/en.2005-1373
Ayoubi Torik A. Y., Meulemans Sandra M. P., Roebroek Anton J. M., Van de Ven Wim J. M., Production of recombinant proteins in Chinese Hamster Ovary cells overexpressing the subtilisin-like proprotein converting enzyme furin, 10.1007/bf00424434
Veugelers M., Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene, 10.1093/hmg/9.9.1321
van de Loo Jan-Willem H. P., Creemers John W. M., Bright Nicholas A., Young Bryan D., Roebroek Anton J. M., Van de Ven Wim J. M., Biosynthesis, Distinct Post-translational Modifications, and Functional Characterization of Lymphoma Proprotein Convertase, 10.1074/jbc.272.43.27116
Anderson E, J. Biol. Chem., 268, 24887 (1993)
Molloy S, EMBO J., 13, 18 (1994)
Benjannet Suzanne, Savaria Diane, Laslop Andrea, Munzer Jon Scott, Chrétien Michel, Marcinkiewicz Mieczyslaw, Seidah Nabil G., α1-Antitrypsin Portland Inhibits Processing of Precursors Mediated by Proprotein Convertases Primarily within the Constitutive Secretory Pathway, 10.1074/jbc.272.42.26210
Fugere M., Appel J., Houghten R. A., Lindberg I., Day R., Short Polybasic Peptide Sequences Are Potent Inhibitors of PC5/6 and PC7: Use of Positional Scanning-Synthetic Peptide Combinatorial Libraries as a Tool for the Optimization of Inhibitory Sequences, 10.1124/mol.106.027946
Roebroek Anton J. M., Taylor Neil A., Louagie Els, Pauli Ilse, Smeijers Liesbeth, Snellinx An, Lauwers Annick, Van de Ven Wim J. M., Hartmann Dieter, Creemers John W. M., Limited Redundancy of the Proprotein Convertase Furin in Mouse Liver, 10.1074/jbc.m407152200
Senzer Neil, Barve Minal, Kuhn Joseph, Melnyk Anton, Beitsch Peter, Lazar Martin, Lifshitz Samuel, Magee Mitchell, Oh Jonathan, Mill Susan W, Bedell Cynthia, Higgs Candice, Kumar Padmasini, Yu Yang, Norvell Fabienne, Phalon Connor, Taquet Nicolas, Rao Donald D, Wang Zhaohui, Jay Chris M, Pappen Beena O, Wallraven Gladice, Brunicardi F Charles, Shanahan David M, Maples Phillip B, Nemunaitis John, Phase I Trial of “bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell” Vaccine (FANG) in Advanced Cancer, 10.1038/mt.2011.269
Revets Hilde, De Baetselier Patrick, Muyldermans Serge, Nanobodies as novel agents for cancer therapy, 10.1517/14712598.5.1.111
Vincke Cécile, Loris Remy, Saerens Dirk, Martinez-Rodriguez Sergio, Muyldermans Serge, Conrath Katja, General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold, 10.1074/jbc.m806889200
De Groeve K., Deschacht N., De Koninck C., Caveliers V., Lahoutte T., Devoogdt N., Muyldermans S., De Baetselier P., Raes G., Nanobodies as Tools for In Vivo Imaging of Specific Immune Cell Types, 10.2967/jnumed.109.070078
Hmila I., Saerens D., Ben Abderrazek R., Vincke C., Abidi N., Benlasfar Z., Govaert J., El Ayeb M., Bouhaouala-Zahar B., Muyldermans S., A bispecific nanobody to provide full protection against lethal scorpion envenoming, 10.1096/fj.09-148213
Declercq, Jeroen
[KULeuven]
Roucourt, Bart
[KULeuven]
Ghassabeh, Gholamreza H
[KULeuven]
Meulemans, Sandra
[KULeuven]
Creemers, John WM
[KULeuven]
